National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

Консенсусный проект Национальных институтов здравоохранения по критериям проведения клинических исследований хронической реакции «трансплантат против хозяина»: V. Доклад рабочей группы по вспомогательной терапии и поддерживающей помощи за 2014 год
Daniel R. Couriel, Nathaniel Simon Treister, Steven Zivko Pavletic, Bipin N. Savani, Stephanie Joi Lee, Anthony W. Opipari, Jörg P. Halter, Carrie Lynn Kitko, Juan Gea‐Banacloche, Mary E.D. Flowers, Paul J. Martin, Karen Leslie Syrjala, Paul A. Carpenter, Sharon Elad, Flora Hoodin, Laura Johnston, Ánita Lawitschka, George B. McDonald, Kirk R. Schultz, Sean Robinson Smith, Georgia B. Vogelsang, Kirsten M. Williams, Laura Johnston
2015-04-06

ancillary therapychronic graft-versus-host diseaseclinical trialssupportive caresystemic immunosuppressive therapy
The 2006 National Institutes of Health (NIH) Consensus paper presented recommendations by the Ancillary Therapy and Supportive Care Working Group to support clinical research trials in chronic graft-versus-host disease (GVHD). Topics covered in that inaugural effort included the prevention and management of infections and common complications of chronic GVHD, as well as recommendations for patient education and appropriate follow-up. Given the new literature that has emerged during the past 8 years, we made further organ-specific refinements to these guidelines. Minimum frequencies are suggested for monitoring key parameters relevant to chronic GVHD during systemic immunosuppressive therapy and, thereafter, referral to existing late effects consensus guidelines is advised. Using the framework of the prior consensus, the 2014 NIH recommendations are organized by organ or other relevant systems and graded according to the strength and quality of supporting evidence.
1
After systemic immunosuppression, the recommendations advise referral to existing consensus guidelines for late effects.
2
Organ-specific refinements address infection prevention, common chronic GVHD complications, patient education, and follow-up care.
3
Recommendations are organized by organ or relevant system and graded according to the strength and quality of supporting evidence.
4
The 2014 NIH consensus report updates recommendations for ancillary therapy and supportive care in chronic graft-versus-host disease clinical trials.
5
The guidelines incorporate new literature published during the eight years since the 2006 consensus recommendations.
6
The report suggests minimum monitoring frequencies for key parameters during systemic immunosuppressive therapy.

Clinical trials in chronic graft-versus-host disease (GVHD)

organ-specific ancillary therapy and supportive-care recommendations, including infection and complication management, monitoring during systemic immunosuppression, patient education, and follow-up

Publication Details
Publication Date
2015-04-06
Journal
Publisher
ISSN
Cited by
241
Access Type
Author Information
Authors
Daniel R. Couriel
Nathaniel Simon Treister
Steven Zivko Pavletic
Bipin N. Savani
Stephanie Joi Lee
Anthony W. Opipari
Jörg P. Halter
Carrie Lynn Kitko
Juan Gea‐Banacloche
Mary E.D. Flowers
Paul J. Martin
Karen Leslie Syrjala
Paul A. Carpenter
Sharon Elad
Flora Hoodin
Laura Johnston
Ánita Lawitschka
George B. McDonald
Kirk R. Schultz
Sean Robinson Smith
Georgia B. Vogelsang
Kirsten M. Williams
Laura Johnston
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%